Hemosiderosis - 22 Studies Found
Completed |
: Efficacy Study in Removing Excess Iron From the Heart :
: 2005-03-15 :
|
Not yet recruiting |
: Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis :
: 2016-01-19 :
|
Terminated |
: Clinical Importance of Treating Iron Overload in Sickle Cell Disease :
: 2009-09-21 : Drug: deferasirox Treatment starting dose of 20mg/kg/day based on subjects baseline LIC (liver iron conc |
Completed |
: Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients :
: 2005-10-14 : Drug: Deferasirox Deferasirox available as 125 mg, 250 mg or 500 mg tablets |
Recruiting |
: Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content :
|
Completed |
: Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions : Beta-Thalassemia : 2003-06-03 :
|
Completed |
: Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload :
|
Completed |
: ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox : Anemia : 2007-04-25 : Drug: Deferasirox |
Withdrawn |
: Treatment of Iron Overload Requiring Chelation Therapy :
|
Enrolling by invitation |
: A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients. :
: 2013-08-07 |